Fri10312014

Last update 10:23:53 AM EST

FDA Requests Further Data on Sarepta's Duchenne Muscular Dystrophy Drug

FDA Requests Further Data on Sarepta's Duchenne Muscular Dystrophy Drug

Sarepta Therapeutics Inc. said that the US Food ...

CTI BioPharma Acquires Worldwide Rights to Anti-Cancer Drug Tosedostat

CTI BioPharma Acquires Worldwide Rights to Anti-Cancer Drug Tosedostat

Blood-related cancer specialist CTI BioPharma ...

CSL to Acquire Novartis' Influenza Vaccine Business

CSL to Acquire Novartis' Influenza Vaccine Business

Today, CSL Limited announced that it will acquir...

AstraZeneca's Ovarian Cancer Drug Gets Backing from EU Agency

AstraZeneca's Ovarian Cancer Drug Gets Backing from EU Agency

Today, AstraZeneca announced that the European...

FDA Extends Review Date for NPS Pharma's Natpara

FDA Extends Review Date for NPS Pharma's Natpara

The US Food and Drug Administration (FDA) has po...

CSL Behring Brings Together the Bleeding Disorder Community at its Junior National Championship Program

CSL Behring Brings Together the Bleeding Disorder Community at its Junior National Championship Program

Today, CSL Behring announced their winners of its 13th Annual Gettin’ in the G...

FDA Approves Baxter's Obizur for Treatment of Acquired Hemophilia A

FDA Approves Baxter's Obizur for Treatment of Acquired Hemophilia A

Today, Baxter International Inc. announced that its hemophilia A drug has been...

Kamada's Glassia Awarded Orphan Drug Designation from the FDA

Kamada's Glassia Awarded Orphan Drug Designation from the FDA

The US Food and Drug Administration (FDA) has granted Orphan Drug designatio...

Google Designing Nanoparticles for Early Detection of Cancer

Google Designing Nanoparticles for Early Detection of Cancer

Google Inc. recently announced that it is working on designing tiny magnetic...

Merck's Lung Cancer Drug Receives Breakthrough Therapy Designation from the FDA

Merck's Lung Cancer Drug Receives Breakthrough Therapy Designation from the FDA

The US Food and Drug Administration (FDA) has granted Merck’s lung cancer drug...

AstraZeneca's Ovarian Cancer Drug Gets Backing from EU Agency

AstraZeneca's Ovarian Cancer Drug Gets Backing from EU Agency

Today, AstraZeneca announced that the European Medicines Agency’s (EMA) Comm...

Bristol-Myers Squibb Enters Option Deal for F-star Alpha and its HER2 Cancer Drug

Bristol-Myers Squibb Enters Option Deal for F-star Alpha and its HER2 Cancer Drug

Bristol-Myers Squibb (BMS) announced that it has signed an exclusive option ...

Dave Walker of Walmart Joins NASP Board of Directors

Dave Walker of Walmart Joins NASP Board of Directors

TAMPA, FL, October 28, 2014 — The National Association of Specialty ...

Takeda Licenses Commercial Rights to Mersana's Fleximer ADC

Takeda Licenses Commercial Rights to Mersana's Fleximer ADC

Today, Mersana Therapeutics, Inc. announced that Takeda’s subsidiary, Millen...

CTI BioPharma Acquires Worldwide Rights to Anti-Cancer Drug Tosedostat

CTI BioPharma Acquires Worldwide Rights to Anti-Cancer Drug Tosedostat

Blood-related cancer specialist CTI BioPharma announced that it has acquired...

CSL to Acquire Novartis' Influenza Vaccine Business

CSL to Acquire Novartis' Influenza Vaccine Business

Today, CSL Limited announced that it will acquire Novartis’ global influenza v...

FDA Requests Further Data on Sarepta's Duchenne Muscular Dystrophy Drug

FDA Requests Further Data on Sarepta's Duchenne Muscular Dystrophy Drug

Sarepta Therapeutics Inc. said that the US Food and Drug Administration (FDA) ...

FDA Extends Review Date for NPS Pharma's Natpara

FDA Extends Review Date for NPS Pharma's Natpara

The US Food and Drug Administration (FDA) has postponed its final decision on ...

Novartis' Secukinumab Demonstrates Positive Results in Spinal Inflammation Trial

Novartis' Secukinumab Demonstrates Positive Results in Spinal Inflammation Trial

Following the US Food and Drug Administration (FDA) advisory group’s unanimous...